Carrier Screening for Thalassemia and Hemoglobinopathies in Canada

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 10, 2008, Pages 950-959

  Langlois, Sylvie ^a   Ford, Jason C ^a   Chitayat, David ^a   Désilets, Valérie A ^a   Farrell, Sandra A ^a   Geraghty, Michael ^a   Nelson, Tanya ^a   Nikkel, Sarah M ^a   Shugar, Andrea ^a   Skidmore, David ^a   Allen, Victoria M ^a   Audibert, François ^a   Blight, Claire ^a   Gagnon, Alain ^a   Johnson, Jo Ann ^a   Douglas Wilson, R ^a   Wyatt, Philip ^a  

^a NONE   (Canada)

Author keywords

Carrier screening; Hemoglobinopathies; Sickle cell disorder; Thalassemia

Indexed keywords

FERRITIN; HEMOGLOBIN A2; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F;

ALPHA THALASSEMIA; AMNIOCENTESIS; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; CANADA; CHORION VILLUS SAMPLING; CLINICAL PRACTICE; DISTRESS SYNDROME; DNA DETERMINATION; ELECTROPHORESIS; FERRITIN BLOOD LEVEL; FETUS HYDROPS; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HEMATOLOGIC DISEASE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOCHROMIA; MEAN CORPUSCULAR VOLUME; MICROCYTOSIS; MOLECULAR BIOLOGY; POSTNATAL CARE; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; QUANTITATIVE ANALYSIS; SICKLE CELL ANEMIA; STAINING; THALASSEMIA; TREATMENT INDICATION;

EID: 59749102422     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32975-9     Document Type: Article

References (28)

1. Chodirker B.N., Cadrin C., Davies G.A.L., Summers A.M., Wilson R.D., Winsor E.J.T., Young D., et al. Canadian guidelines for prenatal diagnosis. Genetic indications for prenatal diagnosis. SOGC Clinical Practice Guideline No. 105, June 2001. J Soc Obstet Gynaecol Can 2001, 23:525-531.
2. Weatherall D.J. The thalassaemias. BMJ 1997, 314:1675-1678.
3. Davies S.C., Cronin E., Gill M., Greengross P., Hickman M., Normand C. Screening for 1sickle 1cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assesstles-source 2000, 4:1-99.
4. Lookopoulos D., Kollia P. Worldwide distribution of âThalassemia. Disorders of hemoglobin. Genetics, pathophysiology, and clinical management 2001, 861-877. Cambridge University Press, Cambridge. M.H. Steinberg, B. Forget, D.R. Higgs, R.L. Nagel (Eds.).
5. Bernini L.F. Geographic distribution of á thalassemia 2001, 878-894. Cambridge University Press, Cambridge. M.H. Steinberg, B. Forget, D.R. Higgs, R.L. Nagel (Eds.).
6. Weatherall D.J., Clegg J.B. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Heath Organization 2001, 79:704-711.
7. Steinberg M.H. Sickle Trait. Disorders of hemoglobin. Genetics, pathophysiology, and clinical management 2001, 811-830. Cambridge University Press, Cambridge. M.H. Steinberg, B. Forget, D.R. Higgs, R.L. Nagel (Eds.).
8. Cao A., Rosatelli M.C., Monni G., Galanello R. Screening for thalassemia. A model of success. Obstet Gynecol Clin N Am 2002, 29:305-328.
9. Leung K.Y., Lee C.P., Tang H.Y., Lau E.T., Ng L.K.L., Lee Y.P., et al. Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong. Prenat Diagn 2004, 24:899-907.
10. Fessas P. Prevention of thalassaemia and haemoglobin S syndromes in Greece. Acta Haematologica 1987, 78:168-172.
11. Khoury M.J., McCabe L.L., McCabe E.R.B. Population screening in the age of genomic medicine. New Engl J Med 2003, 348:50-58.
12. Leung T.N., Lau T.K., Chung T.K.H. Thalassaemia screening in pregnancy. Curr Opin Obstet Gynecol 2005, 17:129-134.
13. Chitayat D., Silver M.M., O'Brien K., Wyatt P., Waye J.S., Chiu D.H., et al. Limb defects in homozygous alpha-thalassemia: report of three cases. Am J Med Genet 1997, 68:162-167.
14. Carbillon L., Oury J.F., Guerin J.M., Zancot A., Blot P. Clinical biological features of Ballantyne Syndrome and the role of placental hydrops. Obstet Gynecol Surv 1997, 52:310-314.
15. Chui D.H., Fucharoen S., Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003, 101:791-800.
16. Bain B. Haemoglobinopathy diagnosis. Oxford: Blackwell Science Ltd.;2001:163. Redding-Lallinger R. Knoll C. Sickle cell disease-pathophysiology and treatment. Curr Probl Pediatr Adolesc Health Care 2006, 36:346-376.
17. ACOG Committee on Obstetrics ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. tles-source. Obstet Gynecol 2007, 109:229-237.
18. Dumars K.W., Boehm C., Eckman J.R., Giardina P.J., Lane P.A., Shafer F.E., for the Council of Regional Networks for Genetic Services (CORN) Practical guide to the diagnosis of thalassemia. Am J Med Genet 1996, 62:29-37.
19. Weatherall D.J., Clegg J.B., Higgs D.R., Wood W.G., Hemoglobin E. The metabolic and molecular basis of inherited disease 2001, 4592. McGraw-Hill, New York. C.R. Scriver, A. Beaudet, W.S. Sly, D. Valle (Eds.).
20. Old J.M. Screening and genetic diagnosis of hemoglobin disorders. Blood Rev 2003, 17:43-53.
21. Skogerboe K.J., West S.F., Smith C., Terashita S.T., LeCrone C.N., Detter J.C., et al. Screening for α-thalassemia. Correlation of hemoglobin H inclusion bodies with DNA-determined genotype. Arch Pathol Lab Med 1992, 116:1012-1018.
22. Lam Y.H., Ghosh A., Tang M.H.Y., Lee C.P., Sin S.Y. Early ultrasound prediction of pregnancies affected by homozygous α-thalassaemia-1. Prenat Diagn 1997, 17:327-332.
23. Tongsong T., Wanapirak C., Sirichotiyakul S., Chanprapaph P. Sonographic markers of hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004, 23:49-55.
24. Mari G., Detti L., Oz U., Zimmerman R., Duerig P., Stefos T. Accurate prediction of fetal hemoglobin by Doppler ultrasonography. Obstet Gynecol 2002, 99:589-593.
25. Imbar T., Lev-Sagie A., Cohen S., Yanai N., Yagel S. Diagnosis, surveillance and treatment of the anemic fetus using middle cerebral artery peak systolic velocity measurement. Prenat Diagn 2006, 26:45-51.
26. Hernandez-Andrade E., Scheier M., Dezerega V., Carmo A., Nicolaides K.H. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops. Ultrasound Obstet Gynecol 2004, 23:442-445.
27. Lam Y.H., Tang M.H.Y. Middle cerebral artery Doppler study in fetuses with homozygous α-thalassaemia-1 at 12-13 weeks of gestation. Prenat Diagn 2002, 22:56-58.
28. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169(3):207-208.